Aggressive amelanotic lentigo maligna. 1994

R I Kelly, and M G Cook, and P S Mortimer
Department of Dermatology, St George's Hospital, London, U.K.

A 66-year-old woman had a long-standing, scaly erythematous lesion on her left temple which histologically showed features of amelanotic lentigo maligna. It had recurred on numerous occasions over a period of 17 years, in spite of multiple attempts at curative surgery. There were also recurrences within a skin graft which, to our knowledge, has not been documented previously with lentigo maligna. In spite of the prolonged course, and extensive intraepidermal melanocytic proliferation amounting to melanoma in situ, there has been no evidence of dermal invasion. The lack of pigmentation in such lesions means that clinical definition of margins is highly inaccurate. In view of the aggressive horizontal growth phase of this lesion, with rapid recurrence following surgery, it was treated with electron beam therapy, and this has resulted in complete clinical remission. This most unusual case illustrates the potential difficulties in diagnosis and management of amelanotic lentigo maligna.

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009364 Neoplasm Recurrence, Local The local recurrence of a neoplasm following treatment. It arises from microscopic cells of the original neoplasm that have escaped therapeutic intervention and later become clinically visible at the original site. Local Neoplasm Recurrence,Local Neoplasm Recurrences,Locoregional Neoplasm Recurrence,Neoplasm Recurrence, Locoregional,Neoplasm Recurrences, Local,Recurrence, Local Neoplasm,Recurrence, Locoregional Neoplasm,Recurrences, Local Neoplasm,Locoregional Neoplasm Recurrences,Neoplasm Recurrences, Locoregional,Recurrences, Locoregional Neoplasm
D011882 Radiotherapy, High-Energy Radiotherapy using high-energy (megavolt or higher) ionizing radiation. Types of radiation include gamma rays, produced by a radioisotope within a teletherapy unit; x-rays, electrons, protons, alpha particles (helium ions) and heavy charged ions, produced by particle acceleration; and neutrons and pi-mesons (pions), produced as secondary particles following bombardment of a target with a primary particle. Megavolt Radiotherapy,High-Energy Radiotherapy,Radiotherapy, Megavolt,High Energy Radiotherapy,Radiotherapy, High Energy
D003131 Combined Modality Therapy The treatment of a disease or condition by several different means simultaneously or sequentially. Chemoimmunotherapy, RADIOIMMUNOTHERAPY, chemoradiotherapy, cryochemotherapy, and SALVAGE THERAPY are seen most frequently, but their combinations with each other and surgery are also used. Multimodal Treatment,Therapy, Combined Modality,Combined Modality Therapies,Modality Therapies, Combined,Modality Therapy, Combined,Multimodal Treatments,Therapies, Combined Modality,Treatment, Multimodal,Treatments, Multimodal
D004583 Electrons Stable elementary particles having the smallest known negative charge, present in all elements; also called negatrons. Positively charged electrons are called positrons. The numbers, energies and arrangement of electrons around atomic nuclei determine the chemical identities of elements. Beams of electrons are called CATHODE RAYS. Fast Electrons,Negatrons,Positrons,Electron,Electron, Fast,Electrons, Fast,Fast Electron,Negatron,Positron
D005153 Facial Neoplasms New abnormal growth of tissue in the FACE. Facial Neoplasm,Neoplasm, Facial,Neoplasms, Facial
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012878 Skin Neoplasms Tumors or cancer of the SKIN. Cancer of Skin,Skin Cancer,Cancer of the Skin,Neoplasms, Skin,Cancer, Skin,Cancers, Skin,Neoplasm, Skin,Skin Cancers,Skin Neoplasm
D018327 Hutchinson's Melanotic Freckle A cellular subtype of malignant melanoma. It is a pigmented lesion composed of melanocytes occurring on sun-exposed skin, usually the face and neck. The melanocytes are commonly multinucleated with a "starburst" appearance. It is considered by many to be the in situ phase of lentigo maligna melanoma. Freckle, Melanotic,Lentigo, Malignant,Melanotic Freckle,Lentigo Maligna,Freckle, Hutchinson's Melanotic,Freckles, Melanotic,Hutchinson Melanotic Freckle,Hutchinsons Melanotic Freckle,Lentigos, Malignant,Malignant Lentigo,Malignant Lentigos,Melanotic Freckle, Hutchinson's,Melanotic Freckles

Related Publications

R I Kelly, and M G Cook, and P S Mortimer
December 1981, The Australasian journal of dermatology,
R I Kelly, and M G Cook, and P S Mortimer
January 1980, Archives of dermatology,
R I Kelly, and M G Cook, and P S Mortimer
July 1998, Journal of the European Academy of Dermatology and Venereology : JEADV,
R I Kelly, and M G Cook, and P S Mortimer
April 1979, Archives of dermatology,
R I Kelly, and M G Cook, and P S Mortimer
September 2002, Journal of the European Academy of Dermatology and Venereology : JEADV,
R I Kelly, and M G Cook, and P S Mortimer
January 2004, Skinmed,
R I Kelly, and M G Cook, and P S Mortimer
February 1995, Journal of the American Academy of Dermatology,
R I Kelly, and M G Cook, and P S Mortimer
July 1998, Journal of the European Academy of Dermatology and Venereology : JEADV,
R I Kelly, and M G Cook, and P S Mortimer
January 1987, Dermatologische Monatschrift,
R I Kelly, and M G Cook, and P S Mortimer
May 2012, The Journal of dermatology,
Copied contents to your clipboard!